Per Venge

TL;DR: The population of the EvA study is different from other COPD study populations, since patients with current oral glucocorticoids, antibiotics and exacerbations or current smokers are excluded, such that the signals detected in the molecular analysis are due to the distinct inflammatory process of emphysema and airway disease in COPD.

TL;DR: The lower levels of myeloperoxidase, lactoferrin and calprotectin during CPB in the HC group indicate that surface modification with end-point attached heparin enhances the biocompatibility of CPB.

TL;DR: Investigation of selected patient characteristics and genetic factors affect HL phenotype, in particular tissue eosinophilia, mast cell counts and HL histological subtype, finds few tumours, surrounded by numerous inflammatory cells.

TL;DR: S-EPO is a promising marker with a higher sensitivity for BHR than S-ECP or B-Eos, and further studies are needed to define the value of S- EPO when following disease activity.

TL;DR: It is concluded that neutrophil expression of CD64 and serum levels of HNL are both promising assays in the distinction between infections caused by bacteria or influenza A, whereas CD64 could identify patients with complications of their influenza A infection.